Gyre Therapeutics, Inc. Short-term Lease, Cost
Gyre Therapeutics, Inc. (GYRE) reported Short-term Lease, Cost of $18.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ShortTermLeaseCost · last filed 2026-08-07
- Gyre Therapeutics, Inc. short-term lease, cost for the quarter ending 2026-06-30 was $18.00K, a 43.75% decline year-over-year.
- Gyre Therapeutics, Inc. short-term lease, cost for the quarter ending 2026-03-31 was $17.00, a 6.25% increase year-over-year.
- Gyre Therapeutics, Inc. short-term lease, cost for the quarter ending 2025-12-31 was $17.00K, a 21.43% increase year-over-year.
- Gyre Therapeutics, Inc. short-term lease, cost for the quarter ending 2025-09-30 was $17.00K, a 10.53% decline year-over-year.
- Gyre Therapeutics, Inc. short-term lease, cost for fiscal 2025 was $66.00K, a 2.94% decline from fiscal 2024.
- Gyre Therapeutics, Inc. short-term lease, cost for fiscal 2024 was $68.00K, a 23.60% decline from fiscal 2023.
- Gyre Therapeutics, Inc. short-term lease, cost for fiscal 2023 was $89.00K, a 71.15% increase from fiscal 2022.
- Gyre Therapeutics, Inc. short-term lease, cost for fiscal 2022 was $52.00K.
| Period end | Short-term Lease, Cost 3 month | Short-term Lease, Cost 3 month as first filed | Short-term Lease, Cost 6 month | Short-term Lease, Cost 9 month | Short-term Lease, Cost 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $18.00K 10-Q · filed 2026-08-07 | $35.00K 10-Q · filed 2026-08-07 | $35.02K derived: sum of 3 quarters · filed 2026-08-07 | $52.02K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $17.00 10-Q · filed 2026-05-08 | $17.02K derived: sum of 2 quarters · filed 2026-05-08 | $34.02K derived: sum of 3 quarters · filed 2026-05-08 | $66.02K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $34.00K derived: sum of 2 quarters · filed 2026-03-13 | $66.00K derived: sum of 3 quarters · filed 2026-08-07 | $66.00K 10-K · filed 2026-03-13 | |
| 2025-09-30 | $17.00K 10-Q · filed 2025-11-07 | $49.00K derived: sum of 2 quarters · filed 2026-08-07 | $49.00K 10-Q · filed 2025-11-07 | $63.02K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $32.00K 10-Q · filed 2026-08-07 | $48.00K 10-Q · filed 2026-08-07 | $46.02K derived: sum of 3 quarters · filed 2026-08-07 | $65.02K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $16.00 10-Q · filed 2026-05-08 | $16.00K 10-Q · filed 2025-05-09 | $14.02K derived: sum of 2 quarters · filed 2026-05-08 | $33.02K derived: sum of 3 quarters · filed 2026-05-08 | $50.02K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $33.00K derived: sum of 2 quarters · filed 2026-03-13 | $50.00K derived: sum of 3 quarters · filed 2026-03-13 | $68.00K 10-K · filed 2026-03-13 | |
| 2024-09-30 | $19.00K 10-Q · filed 2025-11-07 | $36.00K derived: sum of 2 quarters · filed 2025-11-07 | $54.00K 10-Q · filed 2025-11-07 | $71.00K derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | $17.00K 10-Q · filed 2025-08-11 | $35.00K 10-Q · filed 2025-08-11 | $52.00K derived: sum of 3 quarters · filed 2025-08-11 | $74.00K derived: sum of 4 quarters · filed 2025-08-11 | |
| 2024-03-31 | $18.00K 10-Q · filed 2025-05-09 | $35.00K derived: sum of 2 quarters · filed 2025-05-09 | $57.00K derived: sum of 3 quarters · filed 2025-05-09 | $80.00K derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $39.00K derived: sum of 2 quarters · filed 2025-03-17 | $62.00K derived: sum of 3 quarters · filed 2025-03-17 | $89.00K 10-K · filed 2025-03-17 | |
| 2023-09-30 | $22.00K 10-Q · filed 2024-11-13 | $45.00K derived: sum of 2 quarters · filed 2024-11-13 | $72.00K 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $23.00K 10-Q · filed 2024-08-13 | $49.00K 10-Q · filed 2024-08-13 | |||
| 2023-03-31 | $25.00K 10-Q · filed 2024-05-13 | ||||
| 2022-12-31 | $52.00K 10-K · filed 2024-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |